Sagittarius Life Science Corp. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sagittarius Life Science Corp. with three other
companies in this sector in Taiwan:
TSH Biopharm Corp Limited
sales of 515.65 million Taiwanese Dollars [US$17.17 million]
of which 100%
was Drug and Chemical),
Genovate Biotechnology Co., Limited
(455.80 million Taiwanese Dollars [US$15.18 million]
of which 94%
was Medicine Manufacturing), and
Johnson Chemical Pharmaceutical Works Co Ltd
(411.91 million Taiwanese Dollars [US$13.72 million]
Sagittarius Life Science Corp. reported sales of 411.41 million Taiwanese Dollars (US$13.70 million)
December of 2018.
decrease of 11.1%
versus 2017, when the company's sales were 462.82 million Taiwanese Dollars.
Contributing to the drop in overall sales was the 63.5% decline
in Other Department, from 45.74 million Taiwanese Dollars to 16.71 million Taiwanese Dollars.
There were also decreases in sales in
Non-Toxic Sector (down 5.4% to 394.70 million Taiwanese Dollars)